The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Diabetic macular edema can result in low vision or vision ... When fluid gets into the retina’s center part, called the macula, it causes swelling. This can affect vision and, in some cases ...

The macular cube 512 × 128 scan protocol was used to acquire all 128 OCT B-scans that covered an area of 6 × 6 mm and were 2 mm in length centered on the fovea. A mean retinal thickness (RT ...

Geriatrics and Aging. 2008;11(6):333-341. Proliferative diabetic retinopathy is clinically characterized by the growth of new blood vessels that arise from the optic disc and/or retina and ...

Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) or retinal vein occlusion (RVO). Visual impairment and blindness are ...

In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Diabetes can lead to eye problems, and a common one is diabetic macular edema (DME), causing ... senescent cells that propagate disease in the diabetic retina," said the study's lead author ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema ...

The continued evolution of treatment protocols and imaging modalities for the management of retinal diseases ... age-related macular degeneration and diabetic macular edema. Upon successful ...